EVONIK REXIM SAS

Overview

EVONIK REXIM SAS is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering L-ALANYL-L-GLUTAMINE; L-LYSINE HYDRATE; L-PROLINE.

API / Drug Master Files

EVONIK REXIM SAS holds 3 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• L-PROLINEActive2012-09-03
• L-ALANYL-L-GLUTAMINEActive1992-01-03
• L-LYSINE HYDRATEActive1980-07-11
• L-ORNITHINE L-ASPARTATEInactive2020-08-19
• L-ORNITHINE PHENYLACETATEInactive2017-01-02

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EVONIK REXIM SAS in our records. PharmaTek screens the full directory against live FDA enforcement data.